节点文献
肝细胞性肝癌伴癌综合征临床研究
Clinical research on paraneoplastic syndromes in patients with hepatocellular carcinoma
【摘要】 目的研究肝细胞性肝癌(hepatocellular carcinoma,HCC)患者伴癌综合征(paraneoplastic syndromes,PNS)的发病率和临床意义。方法回顾性分析360例HCC患者的生化、影像和病理检查结果,比较PNS组与非PNS组的差异。结果PNS占同期HCC患者住院人数的17.8%(64/360),男女之比为7∶1。PNS主要表现为:低血糖症(占同期HCC患者的9.2%,下同),高胆固醇血症(5.6%),白细胞增多症(5.0%),血小板增多症(3.3%),红细胞增多症(2.8%),高钙血症(1.7%),有两种或两种以上表现者为6.9%(25/360)。与非PNS组相比,PNS组患者的AFP水平、肿瘤直径、门脉癌栓发生率、乙肝病毒感染率和GGT水平显著较高(P<0.05),而生存时间较短(P<0.01)。Cox多因素回归分析显示AFP>800 ng/ml,肿瘤直径>6.5 cm和PNS的发生显著相关(P<0.05)。结论伴PNS的HCC患者预后较差,PNS的发生与AFP水平,肿瘤直径密切相关,熟悉其临床特征有助于早期诊治。
【Abstract】 Objective To investigate the clinical characteristics of paraneoplastic syndromes(PNS) of hepato-cellular carcinoma(HCC).Methods The clinical data of 360 PHC patients were reviewed retrospectively.Re-sults Among the patients with HCC,17.8%(64/360) had PNS,the male-to-female ratio was 7∶1.PNS mainly manifested as six clinical abnormalities: hypoglycemia(9.2%),hypercholesterolemia(5.6%),leucocytosis(5.0%),thrombocytosis(3.3%),erythrocytosis(2.8%) and hypercalcemia(1.7%).Compared with the non-PNS patients,the PNS patients showed statistical differences in the levels of serum AFP,tumor size,incidence of portal vein thromobosis,hepatic virus B infection and serum glutamyltranspeptidase(P<0.05).However,the survival time was relatively shorter(P<0.01).Serum AFP higher than 800 ng/ml and tumor diameter greater than 6.5 cm were found to be predictors for PNS using Cox proportional hazards regression model(P<0.05).Conclusion The clinical manifestations of PNS are nonspecific,which makes it easy to misdiagnosed.In order to make early diagnosis,treatment and improve the prognosis,it is significant to get more knowledge of PNS.
【Key words】 carcinoma,hepatocellular; paraneoplastic syndrome; therapies,investigational;
- 【文献出处】 肝胆胰外科杂志 ,Journal of Hepatopancreatobiliary Surgery , 编辑部邮箱 ,2009年01期
- 【分类号】R735.7
- 【被引频次】5
- 【下载频次】138